oligonucleotide-based microarray platform (Thermo Fisher)
Structured Review
Oligonucleotide Based Microarray Platform, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/the+oligonucleotide-based+microarray+platform/pmc02575954-192-17-20
Average 90 stars, based on 1 article reviews
Images
Related Articles
Gene Expression:Article Title: Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms. Article Snippet: Despite advances in surgical and adjuvant treatments, overall survival of glioblastoma (GBM) patients remains poor.. The cancer stem cell concept suggests that a rare stem cell population, called glioma stem cells (GSCs), has high ability to self-renewal leading to recurrence in GBM.. The identification of specific markers of GSCs would provide a powerful tool to detect and to characterise them in order to develop targeted therapies. Microarray:Article Title: Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms. Article Snippet: Despite advances in surgical and adjuvant treatments, overall survival of glioblastoma (GBM) patients remains poor.. The cancer stem cell concept suggests that a rare stem cell population, called glioma stem cells (GSCs), has high ability to self-renewal leading to recurrence in GBM.. The identification of specific markers of GSCs would provide a powerful tool to detect and to characterise them in order to develop targeted therapies. Expressing:Article Title: Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms. Article Snippet: Despite advances in surgical and adjuvant treatments, overall survival of glioblastoma (GBM) patients remains poor.. The cancer stem cell concept suggests that a rare stem cell population, called glioma stem cells (GSCs), has high ability to self-renewal leading to recurrence in GBM.. The identification of specific markers of GSCs would provide a powerful tool to detect and to characterise them in order to develop targeted therapies. Selection:Article Title: Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms. Article Snippet: Despite advances in surgical and adjuvant treatments, overall survival of glioblastoma (GBM) patients remains poor.. The cancer stem cell concept suggests that a rare stem cell population, called glioma stem cells (GSCs), has high ability to self-renewal leading to recurrence in GBM.. The identification of specific markers of GSCs would provide a powerful tool to detect and to characterise them in order to develop targeted therapies. |
